Literature DB >> 27704152

Treatment of severe MRSA infections: current practice and further development.

José-Artur Paiva1, Philippe Eggimann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27704152     DOI： 10.1007/s00134-016-4572-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

Review 1.  The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

Authors:  S J van Hal; T P Lodise; D L Paterson
Journal:  Clin Infect Dis       Date:  2012-02-02       Impact factor: 9.079

Review 2.  Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond.

Authors:  Natasha E Holmes; Steven Y C Tong; Joshua S Davis; Sebastiaan J van Hal
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

3.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

Review 4.  Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases.

Authors:  Y Gillet; O Dumitrescu; A Tristan; O Dauwalder; E Javouhey; D Floret; F Vandenesch; J Etienne; G Lina
Journal:  Int J Antimicrob Agents       Date:  2011-07-05       Impact factor: 5.283

5.  Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.

Authors:  Natasha E Holmes; John D Turnidge; Wendy J Munckhof; James O Robinson; Tony M Korman; Matthew V N O'Sullivan; Tara L Anderson; Sally A Roberts; Wei Gao; Keryn J Christiansen; Geoffrey W Coombs; Paul D R Johnson; Benjamin P Howden
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

6.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

7.  Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

Authors:  Richard G Wunderink; Michael S Niederman; Marin H Kollef; Andrew F Shorr; Mark J Kunkel; Alice Baruch; William T McGee; Arlene Reisman; Jean Chastre
Journal:  Clin Infect Dis       Date:  2012-01-12       Impact factor: 9.079

8.  Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.

Authors:  Joshua S Davis; Archana Sud; Matthew V N O'Sullivan; James O Robinson; Patricia E Ferguson; Hong Foo; Sebastiaan J van Hal; Anna P Ralph; Benjamin P Howden; Paula M Binks; Adrienne Kirby; Steven Y C Tong; Steven Tong; Joshua Davis; Paula Binks; Suman Majumdar; Anna Ralph; Rob Baird; Claire Gordon; Cameron Jeremiah; Grace Leung; Anna Brischetto; Amy Crowe; Farshid Dakh; Kelly Whykes; Maria Kirkwood; Archana Sud; Mahesh Menon; Lucy Somerville; Shrada Subedi; Shirley Owen; Matthew O'Sullivan; Eunice Liu; Fei Zhou; Owen Robinson; Geoffrey Coombs; Patrician Ferguson; Anna Ralph; Eunice Liu; Simon Pollet; Sebastian Van Hal; Hong Foo; Sebastian Van Hal; Rebecca Davis
Journal:  Clin Infect Dis       Date:  2015-09-08       Impact factor: 9.079

Review 9.  Daptomycin: the role of high-dose and combination therapy for Gram-positive infections.

Authors:  Ian M Gould; José M Miró; Michael J Rybak
Journal:  Int J Antimicrob Agents       Date:  2013-07-08       Impact factor: 5.283

10.  Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Marin L Schweizer; Jon P Furuno; Anthony D Harris; J Kristie Johnson; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; Sara E Cosgrove; George Sakoulas; Eli N Perencevich
Journal:  BMC Infect Dis       Date:  2011-10-19       Impact factor: 3.090
View more
  2 in total

1.  Evaluation of Staphylococcal Bacteriophage Sb-1 as an Adjunctive Agent to Antibiotics Against Rifampin-Resistant Staphylococcus aureus Biofilms.

Authors:  Lei Wang; Tamta Tkhilaishvili; Andrej Trampuz; Mercedes Gonzalez Moreno
Journal:  Front Microbiol       Date:  2020-11-11       Impact factor: 5.640

2.  Dual therapeutic targeting of intra-articular inflammation and intracellular bacteria enhances chondroprotection in septic arthritis.

Authors:  Hyuk-Kwon Kwon; Inkyu Lee; Kristin E Yu; Sean V Cahill; Kareme D Alder; Saelim Lee; Christopher M Dussik; JungHo Back; Jeongjoon Choi; Lee Song; Themis R Kyriakides; Francis Y Lee
Journal:  Sci Adv       Date:  2021-06-25       Impact factor: 14.957
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.